Study of FG-4592 in Non-Dialysis Chronic Kidney Disease Patients With Anaemia

Trial Profile

Study of FG-4592 in Non-Dialysis Chronic Kidney Disease Patients With Anaemia

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Apr 2016

At a glance

  • Drugs Roxadustat (Primary)
  • Indications Anaemia
  • Focus Therapeutic Use
  • Sponsors FibroGen
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 Apr 2016 Results published in Clinical Journal of the American Society of Nephrology, according to a FibroGen media release.
    • 20 Apr 2016 Results published in a FibroGen media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top